Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Citi
Cipla
Express Scripts
QuintilesIMS
Colorcon
Baxter
UBS

Generated: November 19, 2018

DrugPatentWatch Database Preview

Sulfinpyrazone - Generic Drug Details

« Back to Dashboard

What are the generic sources for sulfinpyrazone and what is the scope of sulfinpyrazone patent protection?

Sulfinpyrazone is the generic ingredient in two branded drugs marketed by Novartis, Barr, Ivax Pharms, Par Pharm, Vangard, and Watson Labs, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for sulfinpyrazone.

Summary for sulfinpyrazone
Medical Subject Heading (MeSH) Categories for sulfinpyrazone
Synonyms for sulfinpyrazone
(-+)-sulfinpyrazone
(+/-)-SULFINPYRAZONE
(+/-)-Sulfinpyrazone, analytical standard
1,2-di(phenyl)-4-(2-phenylsulfinylethyl)pyrazolidine-3,5-dione
1,2-Diphenyl-3,5-dioxo- 4- (2-phenylsulfinylethyl) pyrazolidine
1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl) pyrazolidine
1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine
1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin
1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin [German]
1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)-3,5-pyrazolidinedione
1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)pyrazolidine-3,5-dione
1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione
1,2-Diphenyl-4-(phenylsulfinylethyl)-3,5-pyrazolidinedione
1,2-diphenyl-4-[2-(phenylsulfinyl)-ethyl]-pyrazolidine-3,5-dione
1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl-3,5-pyrazolidinedione
1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-1,2-diazolidine-3,5-dione
1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione
1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]pyrazolidine-3,5-dione
3, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-
3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-
3,5-Pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-
32301-EP2281815A1
32301-EP2301933A1
32301-EP2305640A2
32301-EP2311827A1
4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione
4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione
4-(Phenylsulfoxyethyl)-1,5-pyrazolidinedione
4-[2-(benzenesulfinyl)ethyl]-1,2-diphenyl-pyrazolidine-3,5-dione
4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione
57-96-5
8566AB
AB00052103
AB00052103_13
AC-13602
AC1L1K4Z
ACN-S002471
AK122319
AKOS015913283
AN-23594
Anturan
Anturane
Anturane (TN)
Anturanil
Anturano
Anturen
Anturidin
Apo Sulfinpyrazone
Apo-Sulfinpyrazone
Apotex Brand of Sulfinpyrazone
AX8043323
BC206492
BIDD:PXR0096
BPBio1_000220
BRD-A36217750-001-05-6
BRN 0713597
BSPBio_000200
BSPBio_002040
C-21796
C07317
C23H20N2O3S
CAS-57-96-5
CC-00167
CCG-39262
CHEBI:9342
CPD000058991
CTK8F1547
D00449
D03DEI
DB01138
Diphenylpyrazone
DivK1c_000090
DR002388
DSSTox_CID_3618
DSSTox_GSID_23618
DSSTox_RID_77113
DTXSID0023618
EINECS 200-357-4
Enturan
Enturen
FT-0603240
G 28,315
G 28315
G-28315
GTPL5826
HMS1568J22
HMS1921C09
HMS2092K11
HMS2095J22
HMS2233H11
HMS3259I06
HMS3371B22
HMS500E12
HSDB 3396
I14-45370
IDI1_000090
KB-216339
KBio1_000090
KBio2_001502
KBio2_004070
KBio2_006638
KBio3_001540
KBioGR_001449
KBioSS_001502
KS-00000L9C
LS-128688
MBGGBVCUIVRRBF-UHFFFAOYSA-N
MCULE-8521771467
MFCD00057279
MLS000028565
MLS001074941
MolPort-003-666-286
NC00539
NCGC00016255-01
NCGC00016255-02
NCGC00016255-03
NCGC00016255-04
NCGC00016255-05
NCGC00016255-06
NCGC00016255-07
NCGC00016255-10
NCGC00018267-01
NCGC00023932-03
NCGC00023932-04
NINDS_000090
Novartis Brand of Sulfinpyrazone
Novopyrazone
NSC 75925
NSC-757332
NSC-75925
NSC757332
NSC75925
Nu Pharm Brand of Sulfinpyrazone
Nu Sulfinpyrazone
Nu-Pharm Brand of Sulfinpyrazone
Nu-Sulfinpyrazone
Pharmakon1600-01500554
Prestwick_455
Prestwick0_000290
Prestwick1_000290
Prestwick2_000290
Prestwick3_000290
s4628
SAM002554932
SBB058184
SBI-0051528.P003
SCHEMBL34421
SMR000058991
SPBio_001447
SPBio_002419
Spectrum_001022
SPECTRUM1500554
Spectrum2_001324
Spectrum3_000590
Spectrum4_000845
Spectrum5_000984
SR-01000003152
SR-01000003152-2
ST51015125
sufinpyrazone
Sulfinpirazona
Sulfinpirazona [INN-Spanish]
Sulfinpyrazine
Sulfinpyrazon
Sulfinpyrazone (JAN/USP/INN)
Sulfinpyrazone (JP15/USP/INN)
sulfinpyrazone (SPZ)
Sulfinpyrazone [USAN:INN:JAN]
Sulfinpyrazone [USP:INN:BAN:JAN]
Sulfinpyrazone for system suitability, European Pharmacopoeia (EP) Reference Standard
Sulfinpyrazone, European Pharmacopoeia (EP) Reference Standard
Sulfinpyrazone, United States Pharmacopeia (USP) Reference Standard
Sulfinpyrazonum
Sulfinpyrazonum [INN-Latin]
Sulfoxyphenylpyrazolidin
Sulfoxyphenylpyrazolidine
Sulphinpyrazone
suphinpyrazone
Tox21_110331
Tox21_110331_1
TRA0061733
USAF GE-13
W-105427
WLN: T5VNNV EHJ BR& CR& E2SO&R
Z1565440323

US Patents and Regulatory Information for sulfinpyrazone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm SULFINPYRAZONE sulfinpyrazone CAPSULE;ORAL 088934-001 Sep 6, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Barr SULFINPYRAZONE sulfinpyrazone CAPSULE;ORAL 087666-001 Sep 17, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis ANTURANE sulfinpyrazone TABLET;ORAL 011556-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs SULFINPYRAZONE sulfinpyrazone TABLET;ORAL 087667-001 May 26, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Citi
Cipla
Express Scripts
QuintilesIMS
Colorcon
Baxter
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.